BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A; Transplantation Society International CMV Consensus Group. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89:779-795. [PMID: 20224515 DOI: 10.1097/tp.0b013e3181cee42f] [Cited by in Crossref: 437] [Cited by in F6Publishing: 113] [Article Influence: 36.4] [Reference Citation Analysis]
Number Citing Articles
1 La Rosa C, Limaye AP, Krishnan A, Blumstein G, Longmate J, Diamond DJ. Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients. Transpl Int. 2011;24:920-931. [PMID: 21672050 DOI: 10.1111/j.1432-2277.2011.01285.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
2 Waggoner JJ, Pinsky BA. Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues. PeerJ. 2014;2:e334. [PMID: 24765569 DOI: 10.7717/peerj.334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Santos CA, Brennan DC, Fraser VJ, Olsen MA. Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients. Transplant Proc. 2014;46:3585-3592. [PMID: 25498094 DOI: 10.1016/j.transproceed.2014.08.043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
4 O’Shea DT, Humar A. Life-threatening infection in transplant recipients. Crit Care Clin. 2013;29:953-973. [PMID: 24094386 DOI: 10.1016/j.ccc.2013.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
5 Pedersen M, Seetharam A. Infections after orthotopic liver transplantation. J Clin Exp Hepatol. 2014;4:347-360. [PMID: 25755581 DOI: 10.1016/j.jceh.2014.07.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
6 Rozenblyum EV, Allen UD, Silverman ED, Levy DM. Cytomegalovirus infection in childhood-onset systemic lupus erythematosus. Int J Clin Rheumtol. 2013;8:137-146. [PMID: 24527062 DOI: 10.2217/ijr.12.82] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
7 Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep. 2012;14:633-641. [PMID: 22992839 DOI: 10.1007/s11908-012-0292-2] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
8 Reischig T, Hribova P, Jindra P, Hes O, Bouda M, Treska V, Viklicky O. Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. J Am Soc Nephrol 2012;23:1588-97. [PMID: 22917575 DOI: 10.1681/ASN.2012010100] [Cited by in Crossref: 53] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
9 Hirsch HH, Lautenschlager I, Pinsky BA, Cardeñoso L, Aslam S, Cobb B, Vilchez RA, Valsamakis A. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013;56:367-73. [PMID: 23097587 DOI: 10.1093/cid/cis900] [Cited by in Crossref: 102] [Cited by in F6Publishing: 79] [Article Influence: 10.2] [Reference Citation Analysis]
10 Vollmer T, Knabbe C, Dreier J. Systematic Evaluation of Different Nucleic Acid Amplification Assays for Cytomegalovirus Detection: Feasibility of Blood Donor Screening. J Clin Microbiol 2015;53:3219-25. [PMID: 26202109 DOI: 10.1128/JCM.01091-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, Dubberke ER, Husain S, Paterson DL, Chiller T, Pappas P. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study. Transpl Infect Dis 2018;20:e12877. [PMID: 29512935 DOI: 10.1111/tid.12877] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Martiny PB, de-Paris F, Machado AB, Mello RO, Senger MB, Corrêa MC, Werres Junior LC, de Souza CF. Comparison of the performance of polymerase chain reaction and pp65 antigenemia for the detection of human cytomegalovirus in immunosuppressed patients. Rev Soc Bras Med Trop 2011;44:286-9. [PMID: 21625804 DOI: 10.1590/s0037-86822011005000029] [Reference Citation Analysis]
13 Chou S, Ercolani RJ, Vanarsdall AL. Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591 to 603 of the Cytomegalovirus UL97 Kinase Gene. J Clin Microbiol 2017;55:2098-104. [PMID: 28446569 DOI: 10.1128/JCM.00391-17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
14 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Boppana SB, Britt WJ. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines. Methods Mol Biol 2021;2244:403-63. [PMID: 33555597 DOI: 10.1007/978-1-0716-1111-1_19] [Reference Citation Analysis]
16 Chou S, Bowlin TL. Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. Antimicrob Agents Chemother 2011;55:382-4. [PMID: 21041510 DOI: 10.1128/AAC.01259-10] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
17 Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O’Riordan A, Burroughs AK. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant. 2012;12:2457-2464. [PMID: 22594993 DOI: 10.1111/j.1600-6143.2012.04087.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 11.4] [Reference Citation Analysis]
18 BenMarzouk-Hidalgo OJ, Cordero E, Gómez-Cía T, Sánchez M, González-Padilla JD, Infante-Cossio P, Sicilia-Castro D, Hernández-Guisado JM, Pérez-Romero P. First face composite-tissue transplant recipient successfully treated for cytomegalovirus infection with preemptive valganciclovir treatment. Antimicrob Agents Chemother 2011;55:5949-51. [PMID: 21968361 DOI: 10.1128/AAC.05335-11] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
19 Sommerwerck U, Rabis T, Fleimisch P, Carstens H, Teschler H, Kamler M. [Lung transplantation]. Herz 2014;39:74-83. [PMID: 24477632 DOI: 10.1007/s00059-013-4044-3] [Reference Citation Analysis]
20 Sims KD, Blumberg EA. Common infections in the lung transplant recipient. Clin Chest Med 2011;32:327-41. [PMID: 21511093 DOI: 10.1016/j.ccm.2011.02.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
21 Khanna R. Immune Monitoring of Infectious Complications in Transplant Patients: an Important Step towards Improved Clinical Management. J Clin Microbiol 2018;56:e02009-17. [PMID: 29343541 DOI: 10.1128/JCM.02009-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
22 Rha B, Redden D, Benfield M, Lakeman F, Whitley RJ, Shimamura M. Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant 2012;16:627-37. [PMID: 22694244 DOI: 10.1111/j.1399-3046.2012.01741.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
23 Santos CA, Brennan DC, Yusen RD, Olsen MA. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients. Transplantation 2015;99:1658-66. [PMID: 25675196 DOI: 10.1097/TP.0000000000000549] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 3.9] [Reference Citation Analysis]
24 Chou S, Ercolani RJ, Marousek G, Bowlin TL. Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance. Antimicrob Agents Chemother 2013;57:3375-9. [PMID: 23650173 DOI: 10.1128/AAC.00511-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
25 Santos CA, Brennan DC, Saeed MJ, Fraser VJ, Olsen MA. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage. Clin Transplant 2016;30:435-44. [PMID: 26841129 DOI: 10.1111/ctr.12706] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Emery VC. Human herpesvirus vaccines and future directions. Am J Transplant 2013;13 Suppl 3:79-86; quiz 86. [PMID: 23347216 DOI: 10.1111/ajt.12007] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA. Priorities for CMV vaccine development. Vaccine 2013;32:4-10. [PMID: 24129123 DOI: 10.1016/j.vaccine.2013.09.042] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 11.8] [Reference Citation Analysis]
28 Lee CY, Chen YH, Lu PL. Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review. BMC Infect Dis. 2017;17:113. [PMID: 28143418 DOI: 10.1186/s12879-017-2218-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Comoli P, Ginevri F. Monitoring and managing viral infections in pediatric renal transplant recipients. Pediatr Nephrol 2012;27:705-17. [PMID: 21359619 DOI: 10.1007/s00467-011-1812-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
30 Frenzel K, Lehmann J, Krüger DH, Martin-Parras L, Uharek L, Hofmann J. Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection. Med Microbiol Immunol 2014;203:115-23. [PMID: 24337366 DOI: 10.1007/s00430-013-0321-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
31 Sahoo MK, Lefterova MI, Yamamoto F, Waggoner JJ, Chou S, Holmes SP, Anderson MW, Pinsky BA. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing. J Clin Microbiol 2013;51:3700-10. [PMID: 23985916 DOI: 10.1128/JCM.01605-13] [Cited by in Crossref: 63] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
32 Frickmann H, Masanta WO, Zautner AE. Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management. Biomed Res Int 2014;2014:375681. [PMID: 25343142 DOI: 10.1155/2014/375681] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
33 Liu Y, Freed DC, Li L, Tang A, Li F, Murray EM, Adler SP, McVoy MA, Rupp RE, Barrett D, Ye X, Zhang N, Beck K, Culp T, Das R, Song L, Vora K, Zhu H, Wang D, Espeseth AS, An Z, Musey L, Fu TM. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection. J Virol 2019;93:e00747-19. [PMID: 31511385 DOI: 10.1128/JVI.00747-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
34 Awad SM, Ali SM, Mansour YE, Fatahala SS. Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents. Molecules 2021;26:2988. [PMID: 34069874 DOI: 10.3390/molecules26102988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Camacho-Gonzalez AF, Gutman J, Hymes LC, Leong T, Hilinski JA. 24 weeks of valganciclovir prophylaxis in children after renal transplantation: a 4-year experience. Transplantation 2011;91:245-50. [PMID: 21076375 DOI: 10.1097/TP.0b013e3181ffffd3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
36 Tanaka A, Yamashita C, Hinogami H, Shirai H, Matsuura A. Cytomegalovirus-induced vasculopathy and anogenital skin ulcers in a patient with multiple myeloma. JAAD Case Rep 2020;6:57-9. [PMID: 31909141 DOI: 10.1016/j.jdcr.2019.04.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
37 Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018;67:e1-e94. [PMID: 29955859 DOI: 10.1093/cid/ciy381] [Cited by in Crossref: 131] [Cited by in F6Publishing: 98] [Article Influence: 43.7] [Reference Citation Analysis]
38 Li L, Freed DC, Liu Y, Li F, Barrett DF, Xiong W, Ye X, Adler SP, Rupp RE, Wang D, Zhang N, Fu TM, An Z. A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. NPJ Vaccines 2021;6:79. [PMID: 34078915 DOI: 10.1038/s41541-021-00342-3] [Reference Citation Analysis]
39 Melero-Ferrer J, Sanchez-Lazaro IJ, Navea-Tejerina A, Almenar-Bonet L, Blanes-Julia M, Martinez-Dolz L, Salvador-Sanz A. Repeated CMV infection in a heart transplantation patient. Case Rep Transplant 2012;2012:305920. [PMID: 23213610 DOI: 10.1155/2012/305920] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Tanné C, Roy P, Frobert É, Duncan A, Laurent A, Cochat P. Cytomegalovirus infection in the first year after pediatric kidney transplantation. Nephrol Ther 2019;15:44-50. [PMID: 29887270 DOI: 10.1016/j.nephro.2018.04.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Meesing A, Razonable RR. New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs. 2018;78:1085-1103. [PMID: 29961185 DOI: 10.1007/s40265-018-0943-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
42 Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol 2011; 3(4): 83-92 [PMID: 21603030 DOI: 10.4254/wjh.v3.i4.83] [Cited by in Crossref: 97] [Cited by in F6Publishing: 69] [Article Influence: 8.8] [Reference Citation Analysis]
43 Simon P, Sasse M, Laudi S, Petroff D, Bartels M, Kaisers UX, Bercker S. Two strategies for prevention of cytomegalovirus infections after liver transplantation. World J Gastroenterol 2016; 22(12): 3412-3417 [PMID: 27022223 DOI: 10.3748/wjg.v22.i12.3412] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Costa FA, Soki MN, Andrade PD, Bonon SH, Thomasini RL, Sampaio AM, Ramos Mde C, Rossi CL, Cavalcanti TC, Boin Ide F. Simultaneous monitoring of CMV and human herpesvirus 6 infections and diseases in liver transplant patients: one-year follow-up. Clinics (Sao Paulo). 2011;66:949-953. [PMID: 21808857 DOI: 10.1590/s1807-59322011000600005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, Ison M, Humar A, Padera RF, Lawler LP, Fisher A, Drew RJ, Gould KF, Sole A, Studer S, Munoz P, Singer LG, Hannan M; ISHLT Infectious Diseases Council Working Group on Definitions. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011;30:361-74. [PMID: 21419994 DOI: 10.1016/j.healun.2011.01.701] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 10.8] [Reference Citation Analysis]
46 Meyer KC. Lung transplantation. F1000Prime Rep 2013;5:16. [PMID: 23710330 DOI: 10.12703/P5-16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol 2010; 2(9): 325-336 [PMID: 21161017 DOI: 10.4254/wjh.v2.i9.325] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
48 Griffiths PD, Rothwell E, Raza M, Wilmore S, Doyle T, Harber M, O'Beirne J, Mackinnon S, Jones G, Thorburn D, Mattes F, Nebbia G, Atabani S, Smith C, Stanton A, Emery VC. Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy. PLoS One 2016;11:e0163722. [PMID: 27684379 DOI: 10.1371/journal.pone.0163722] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
49 Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol. 2011;85:10884-10893. [PMID: 21752907 DOI: 10.1128/jvi.05265-11] [Cited by in Crossref: 201] [Cited by in F6Publishing: 80] [Article Influence: 18.3] [Reference Citation Analysis]
50 Maguire O, Tario JD Jr, Shanahan TC, Wallace PK, Minderman H. Flow cytometry and solid organ transplantation: a perfect match. Immunol Invest 2014;43:756-74. [PMID: 25296232 DOI: 10.3109/08820139.2014.910022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
51 Tan BH. Cytomegalovirus Treatment. Curr Treat Options Infect Dis 2014;6:256-70. [PMID: 25999800 DOI: 10.1007/s40506-014-0021-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
52 Squires JE, Sisk RA, Balistreri WF, Kohli R. Isolated unilateral cytomegalovirus retinitis: a rare long-term complication after pediatric liver transplantation. Pediatr Transplant 2013;17:E16-9. [PMID: 22738313 DOI: 10.1111/j.1399-3046.2012.01752.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Verma Y, Gupta E, Kumar N, Hasnain N, Bhadoria AS, Pamecha V, Khanna R. Earlier and higher rates of cytomegalovirus infection in pediatric liver transplant recipients as compared to adults: An observational study. J Lab Physicians. 2018;10:221-225. [PMID: 29692591 DOI: 10.4103/jlp.jlp_140_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Gioco R, Puzzo L, Patanè M, Corona D, Trama G, Veroux P, Veroux M. Post-transplant colitis after kidney transplantation: clinical, endoscopic and histological features. Aging (Albany NY) 2020;12:24709-20. [PMID: 33353887 DOI: 10.18632/aging.202345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Yuan J, Li M, Torres YR, Galle CS, Meier JL. Differentiation-Coupled Induction of Human Cytomegalovirus Replication by Union of the Major Enhancer Retinoic Acid, Cyclic AMP, and NF-κB Response Elements. J Virol 2015;89:12284-98. [PMID: 26423948 DOI: 10.1128/JVI.00965-15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
56 Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P. Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma. PLoS One 2013;8:e60767. [PMID: 23593305 DOI: 10.1371/journal.pone.0060767] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
57 Draz MS, Shafiee H. Applications of gold nanoparticles in virus detection. Theranostics 2018;8:1985-2017. [PMID: 29556369 DOI: 10.7150/thno.23856] [Cited by in Crossref: 114] [Cited by in F6Publishing: 80] [Article Influence: 28.5] [Reference Citation Analysis]
58 de Matos SB, Meyer R, Lima FWM. Cytomegalovirus Infection after Renal Transplantation: Occurrence, Clinical Features, and the Cutoff for Antigenemia in a University Hospital in Brazil. Infect Chemother 2017;49:255-61. [PMID: 29299892 DOI: 10.3947/ic.2017.49.4.255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis 2012;54:1793-7. [PMID: 22412060 DOI: 10.1093/cid/cis212] [Cited by in Crossref: 97] [Cited by in F6Publishing: 73] [Article Influence: 9.7] [Reference Citation Analysis]
60 Pellett Madan R, Allen UD, Green M, Höcker B, Michaels MG, Varela-Fascinetto G, Danziger-Isakov L; Pediatric Subgroup for the International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation and the International Pediatric Transplant Association Infectious Disease Committee. Pediatric transplantation case conference: Update on cytomegalovirus. Pediatr Transplant 2018;22:e13276. [PMID: 30203626 DOI: 10.1111/petr.13276] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Snyder LD, Medinas R, Chan C, Sparks S, Davis WA, Palmer SM, Weinhold KJ. Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis. Am J Transplant 2011;11:553-60. [PMID: 21219584 DOI: 10.1111/j.1600-6143.2010.03405.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
62 Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA. Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients. Drug Des Devel Ther 2012;6:289-95. [PMID: 23091373 DOI: 10.2147/DDDT.S36578] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
63 Moreno Camacho A, Rodríguez Benot A. [Prophylaxis of cytomegalovirus infection in pancreatic transplantation]. Enferm Infecc Microbiol Clin 2011;29 Suppl 6:56-9. [PMID: 22541925 DOI: 10.1016/S0213-005X(11)70060-X] [Reference Citation Analysis]
64 McGee J, Mave V, Yau CL, Killackey M, Paramesh A, Buell J, Slakey DP, Hamm LL, Zhang R. Cytomegalovirus disease in African-American kidney transplant patients. Transpl Infect Dis 2012;14:604-10. [PMID: 23228184 DOI: 10.1111/j.1399-3062.2012.00759.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
65 Lin H, Chen L, Wen S, Yue Z, Mo Y, Jiang X, Huang L. Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review. Ren Fail 2020;42:776-84. [PMID: 32757688 DOI: 10.1080/0886022X.2020.1800491] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Göhring K, Hamprecht K, Jahn G. Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients. Comput Struct Biotechnol J 2015;13:153-9. [PMID: 25750703 DOI: 10.1016/j.csbj.2015.01.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
67 Emery VC, Asher K, Sanjuan Cde J. Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation. J Clin Virol 2012;54:125-9. [PMID: 22445261 DOI: 10.1016/j.jcv.2012.02.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
68 Filiponi TC, Requião-Moura LR, Tonato EJ, Carvalho de Matos AC, E Silva-Filho AP, de Souza Durão Junior M. Hospital Admission following Acute Kidney Injury in Kidney Transplant Recipients Is Associated with a Negative Impact on Graft Function after 1-Year. PLoS One 2015;10:e0138944. [PMID: 26417949 DOI: 10.1371/journal.pone.0138944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
69 Greiner M, Cusini A, Ruesch M, Schiesser M, Ledergerber B, Fehr T, Mueller NJ. A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation. Infection. 2012;40:669-675. [PMID: 23015480 DOI: 10.1007/s15010-012-0343-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
70 Witt CA, Meyers BF, Hachem RR. Pulmonary infections following lung transplantation. Thorac Surg Clin 2012;22:403-12. [PMID: 22789602 DOI: 10.1016/j.thorsurg.2012.04.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
71 Egli A, Silva M Jr, O'Shea D, Wilson LE, Baluch A, Lisboa LF, Hidalgo LG, Kumar D, Humar A. An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients. PLoS One 2012;7:e43937. [PMID: 23071829 DOI: 10.1371/journal.pone.0043937] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
72 Emery VC. Cytomegalovirus: recent progress in understanding pathogenesis and control. QJM 2012;105:401-5. [PMID: 22198913 DOI: 10.1093/qjmed/hcr262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
73 Pillet S, Bourlet T, Pozzetto B. Comparative evaluation of the QIAsymphony RGQ system with the easyMAG/R-gene combination for the quantitation of cytomegalovirus DNA load in whole blood. Virol J 2012;9:231. [PMID: 23046712 DOI: 10.1186/1743-422X-9-231] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
74 Vaz R, Barros F, Tavares I, Bustorff M, Ferreira I, Pestana M. Ganciclovir-resistant cytomegalovirus infection in renal transplantation. Clin Kidney J 2014;7:210-3. [PMID: 25852874 DOI: 10.1093/ckj/sfu005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Jensen KO, Angst E, Hetzer FH, Gingert C. Acute Cytomegalovirus Hepatitis in an Immunocompetent Host as a Reason for Upper Right Abdominal Pain. Case Rep Gastroenterol 2016;10:36-43. [PMID: 27403100 DOI: 10.1159/000442972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
76 Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010;23:689-712. [PMID: 20930070 DOI: 10.1128/cmr.00009-10] [Cited by in Crossref: 371] [Cited by in F6Publishing: 156] [Article Influence: 30.9] [Reference Citation Analysis]
77 Kim JM, Joh JW, Kim HJ, Kim SH, Rha M, Sinn DH, Choi GS, Kwon CH, Cho YY, Suh JM, Lee SK. Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot Study. Medicine (Baltimore) 2015;94:e1771. [PMID: 26554774 DOI: 10.1097/MD.0000000000001771] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
78 Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol 2014; 20(31): 10658-10667 [PMID: 25152570 DOI: 10.3748/wjg.v20.i31.10658] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
79 Mishra V, Nayak P, Sharma M, Albutti A, Alwashmi ASS, Aljasir MA, Alsowayeh N, Tambuwala MM. Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update. Pharmaceutics 2021;13:1568. [PMID: 34683861 DOI: 10.3390/pharmaceutics13101568] [Reference Citation Analysis]
80 Gable JE, Acker TM, Craik CS. Current and potential treatments for ubiquitous but neglected herpesvirus infections. Chem Rev 2014;114:11382-412. [PMID: 25275644 DOI: 10.1021/cr500255e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
81 Benden C. Pediatric lung transplantation. J Thorac Dis 2017;9:2675-83. [PMID: 28932575 DOI: 10.21037/jtd.2017.07.84] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
82 Forman M, Wilson A, Valsamakis A. Cytomegalovirus DNA quantification using an automated platform for nucleic acid extraction and real-time PCR assay setup. J Clin Microbiol 2011;49:2703-5. [PMID: 21562101 DOI: 10.1128/JCM.00721-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
83 Gracia-Ahufinger I, Torre-Cisneros J. [Cytomegalovirus infection in renal transplantation: from learned lessons to future challenges]. Med Clin (Barc) 2011;137:349-51. [PMID: 21524770 DOI: 10.1016/j.medcli.2011.02.021] [Reference Citation Analysis]
84 Lemonovich TL, Watkins RR. Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients. Curr Infect Dis Rep. 2012;14:33-40. [PMID: 22125047 DOI: 10.1007/s11908-011-0224-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
85 Schenk W, Klugmann T, Borkenhagen A, Klecker C, Dietel P, Kirschner R, Schneider E, Bruns T, Stallmach A, Teich N. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic. Int J Colorectal Dis. 2019;34:393-400. [PMID: 30506156 DOI: 10.1007/s00384-018-3210-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
86 Verghese PS, Schleiss MR. Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent. Drugs Future 2013;38:291-8. [PMID: 24163496 DOI: 10.1358/dof.2013.038.05.1946425] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
87 Costa C, Saldan A, Cavallo R. Evaluation of virus-specific cellular immune response in transplant patients. World J Virol 2012; 1(6): 150-153 [PMID: 24175220 DOI: 10.5501/wjv.v1.i6.150] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
88 Shimamura M, Saunders U, Rha B, Guo L, Cassady KA, George JF, Britt WJ. Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation. Transplantation 2011;92:759-66. [PMID: 21878840 DOI: 10.1097/TP.0b013e31822c6e89] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
89 de Sandes-Freitas TV, Pinheiro PMA, Sales MLMBO, Girão CM, Campos ÉF, Esmeraldo RM. The impact of everolimus in reducing cytomegalovirus events in kidney transplant recipients on steroid-avoidance strategy: 3-year follow-up of a randomized clinical trial. Transpl Int 2018;31:1345-56. [PMID: 29969826 DOI: 10.1111/tri.13313] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
90 Gantt S, Casper C. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis. 2011;24:295-301. [PMID: 21666458 DOI: 10.1097/qco.0b013e3283486d04] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
91 Dasari V, Smith C, Schuessler A, Zhong J, Khanna R. Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity. Hum Vaccin Immunother 2014;10:1064-77. [PMID: 24463331 DOI: 10.4161/hv.27675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
92 Durand CM, Marr KA, Arnold CA, Tang L, Durand DJ, Avery RK, Valsamakis A, Neofytos D. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis. 2013;57:1550-1559. [PMID: 23956167 DOI: 10.1093/cid/cit521] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
93 Holmes-Liew CL, Holmes M, Beagley L, Hopkins P, Chambers D, Smith C, Khanna R. Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation. Clin Transl Immunology 2015;4:e35. [PMID: 25859390 DOI: 10.1038/cti.2015.5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
94 Requião-Moura LR, deMatos AC, Pacheco-Silva A. Cytomegalovirus infection in renal transplantation: clinical aspects, management and the perspectives. Einstein (Sao Paulo) 2015;13:142-8. [PMID: 25993081 DOI: 10.1590/S1679-45082015RW3175] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
95 Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013;45:260-271. [PMID: 24396627 DOI: 10.3947/ic.2013.45.3.260] [Cited by in Crossref: 168] [Cited by in F6Publishing: 137] [Article Influence: 18.7] [Reference Citation Analysis]
96 Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, Kasahara K, Kadota J, Kishida N, Kobayashi O, Sakata H, Seki M, Tsukada H, Tokue Y, Nakamura-Uchiyama F, Higa F, Maeda K, Yanagihara K, Yoshida K. JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG. J Infect Chemother 2016;22:S1-S65. [PMID: 27317161 DOI: 10.1016/j.jiac.2015.12.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
97 Dekeyser M, Ladrière M, Audonnet S, Frimat L, De Carvalho Bittencourt M. An Early Immediate Early Protein IE-1-Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation. Kidney Int Rep 2017;2:486-92. [PMID: 29142976 DOI: 10.1016/j.ekir.2017.02.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
98 Forlanini F, Dara J, Dvorak CC, Cowan MJ, Puck JM, Dorsey MJ. Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients. Transpl Infect Dis 2021;23:e13504. [PMID: 33169931 DOI: 10.1111/tid.13504] [Reference Citation Analysis]
99 Ziemann M, Hennig H. Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy? Transfus Med Hemother 2014;41:40-4. [PMID: 24659946 DOI: 10.1159/000357102] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
100 Patel SJ, Kuten SA, Knight RJ, Hong DM, Gaber AO. Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin. J Transplant 2014;2014:342319. [PMID: 24991428 DOI: 10.1155/2014/342319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
101 Hakki M, Chou S. The biology of cytomegalovirus drug resistance. Curr Opin Infect Dis. 2011;24:605-611. [PMID: 22001948 DOI: 10.1097/qco.0b013e32834cfb58] [Cited by in Crossref: 72] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
102 Breda G, Almeida B, Carstensen S, Bonfim CM, Nogueira MB, Vidal LR, Almeida SM, Raboni SM. Human cytomegalovirus detection by real-time PCR and pp65-antigen test in hematopoietic stem cell transplant recipients: a challenge in low and middle-income countries. Pathog Glob Health 2013;107:312-9. [PMID: 24188241 DOI: 10.1179/2047773213Y.0000000114] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
103 Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121. [PMID: 23845951 DOI: 10.1093/cid/cit278] [Cited by in Crossref: 298] [Cited by in F6Publishing: 213] [Article Influence: 33.1] [Reference Citation Analysis]
104 Schnepf N, Scieux C, Resche-Riggon M, Feghoul L, Xhaard A, Gallien S, Molina JM, Socié G, Viglietti D, Simon F, Mazeron MC, Legoff J. Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard. J Clin Microbiol 2013;51:2096-102. [PMID: 23616450 DOI: 10.1128/JCM.00067-13] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
105 Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O’Beirne J. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet. 2011;377:1256-1263. [PMID: 21481708 DOI: 10.1016/s0140-6736(11)60136-0] [Cited by in Crossref: 293] [Cited by in F6Publishing: 148] [Article Influence: 26.6] [Reference Citation Analysis]
106 Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020;111:102468. [PMID: 32317220 DOI: 10.1016/j.jaut.2020.102468] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 30.5] [Reference Citation Analysis]
107 Paulsen G, Cumagun P, Mixon E, Fowler K, Feig D, Shimamura M. Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis. Pediatr Transplant 2019;23:e13382. [PMID: 30786115 DOI: 10.1111/petr.13382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
108 Ravkov EV, Pavlov IY, Hanson KE, Delgado JC. Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant. Clin Dev Immunol 2012;2012:451059. [PMID: 23304188 DOI: 10.1155/2012/451059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
109 Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, Peracchi M, Furian L, Cusinato R, Bonfante L, Rossi B, Marchini F, Sgarabotto D, Rigotti P, Palù G. Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients. J Clin Microbiol 2013;51:2501-7. [PMID: 23678073 DOI: 10.1128/JCM.00563-13] [Cited by in Crossref: 62] [Cited by in F6Publishing: 24] [Article Influence: 6.9] [Reference Citation Analysis]
110 Allen U, Green M. The menace of CMV disease after small bowel transplantation: bearer of bad news! Pediatr Transplant 2012;16:545-8. [PMID: 22574878 DOI: 10.1111/j.1399-3046.2012.01715.x] [Reference Citation Analysis]
111 Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc 2011;86:1009-26. [PMID: 21964179 DOI: 10.4065/mcp.2011.0309] [Cited by in Crossref: 137] [Cited by in F6Publishing: 106] [Article Influence: 12.5] [Reference Citation Analysis]
112 Sobieszczańska-Małek M, Korewicki J, Komuda K, Karczmarz M, Szymańska S, Cicha-Mikołajczyk A, Bekta P, Parulski A, Pronicki M, Grajkowska W, Małek G, Leszek P, Kaczorowska M, Kuśmierczyk M, Zieliński T. Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important? Ann Transplant 2017;22:682-8. [PMID: 29146891 DOI: 10.12659/aot.905267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
113 Ponz de Antonio I, Rodríguez Chaverri A, García Reyne A, Carrasco Antón N, Lora Pablos D, López Medrano F, de Dios S, Jurado A, Folgueira MD, García-Cosio Carmena MD, Arribas Ynsaurriaga F, Aguado JM, Lumbreras C, Delgado Jiménez JF. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients. Transpl Infect Dis 2021;23:e13479. [PMID: 32996216 DOI: 10.1111/tid.13479] [Reference Citation Analysis]
114 Bachmann R, Hamprecht K, Lange J, Ladurner R, Nadalin S, Jahn G, Königsrainer A, Heininger A. Successful ganciclovir treatment of primary cytomegalovirus infection containing the UL97 mutation N510S in an intestinal graft recipient. Infection 2013;41:875-9. [PMID: 23546999 DOI: 10.1007/s15010-013-0458-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
115 Krishna NK, Cunnion KM. Role of molecular diagnostics in the management of infectious disease emergencies. Med Clin North Am 2012;96:1067-78. [PMID: 23102477 DOI: 10.1016/j.mcna.2012.08.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
116 Bal TA, Armstrong G, Han XY. Evaluation of the IMMULITE® 2000 CMV IgM assay. Herpesviridae 2012;3:2. [PMID: 22377002 DOI: 10.1186/2042-4280-3-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
117 Burguete SR, Maselli DJ, Fernandez JF, Levine SM. Lung transplant infection. Respirology 2013;18:22-38. [PMID: 22591266 DOI: 10.1111/j.1440-1843.2012.02196.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
118 Santiago JL, Pérez-Flores I, Sánchez-Pérez L, Moreno de la Higuera MA, Calvo-Romero N, Querol-García J, Culebras E, Urcelay E, Fernández-Pérez C, Sánchez-Fructuoso AI. The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation. Front Immunol 2019;10:2994. [PMID: 31998298 DOI: 10.3389/fimmu.2019.02994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Abou-Jaoudé M, El Hage S, Akiki D, Fadlallah M, Ghaith AK, Dib A. Cytomegalovirus infection in kidney transplant patients: Prevalence, risk factors, and impact on outcome - A local multicentre experience. Transpl Immunol 2021;69:101473. [PMID: 34547416 DOI: 10.1016/j.trim.2021.101473] [Reference Citation Analysis]
120 Kim SJ, Rhu J, Yoo H, Kim K, Lee KW, Park JB. Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation. J Clin Med 2020;9:E1320. [PMID: 32370265 DOI: 10.3390/jcm9051320] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
121 Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract 2018;37:323-37. [PMID: 30619688 DOI: 10.23876/j.krcp.18.0063] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
122 Marques S, Carmo J, Pinto D, Bispo M, Ramos S, Chagas C. Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Retrospective Study. GE Port J Gastroenterol 2017;24:262-8. [PMID: 29255766 DOI: 10.1159/000479232] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
123 Chou S. Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy. J Clin Virol 2011;50:287-91. [PMID: 21295516 DOI: 10.1016/j.jcv.2011.01.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
124 Bommer M, Michel D. Prevention of cytomegalovirus disease in patients with impaired cell-mediated immunity – is there a need for maribavir? Expert Opinion on Orphan Drugs 2013;1:829-36. [DOI: 10.1517/21678707.2013.842166] [Reference Citation Analysis]
125 Hirche TO, Knoop C, Hebestreit H, Shimmin D, Solé A, Elborn JS, Ellemunter H, Aurora P, Hogardt M, Wagner TO; ECORN-CF Study Group. Practical guidelines: lung transplantation in patients with cystic fibrosis. Pulm Med 2014;2014:621342. [PMID: 24800072 DOI: 10.1155/2014/621342] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
126 Cantisán S, Martín C, Romero-Sánchez MC, Ferrando-Martínez S, Martínez F, Rivero A, Torres A, Solana R, Torre-Cisneros J. Role of defective thymic function in onset of ganciclovir-resistant cytomegalovirus after cord blood transplantation. Clin Vaccine Immunol 2012;19:1994-8. [PMID: 23054743 DOI: 10.1128/CVI.00407-12] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
127 Bedel AN, Hemmelgarn TS, Kohli R. Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir. Liver Transpl 2012;18:347-54. [PMID: 22139888 DOI: 10.1002/lt.22471] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
128 Gioco R, Corona D, Ekser B, Puzzo L, Inserra G, Pinto F, Schipa C, Privitera F, Veroux P, Veroux M. Gastrointestinal complications after kidney transplantation. World J Gastroenterol 2020; 26(38): 5797-5811 [PMID: 33132635 DOI: 10.3748/wjg.v26.i38.5797] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]